Predictive Technology Group
Predictive Laboratories’ discoveries in molecular and genetic diagnostics focus on unmet needs in women’s health, infertility and other diseases. Predictive offers earlier detection of disease through genetic assessment to guide personalized precision medicine. Leveraging its vast genetic database, Predictive enables the discovery of genes and gene mutations that identify hard-to-diagnose and detect diseases and their prognosis.
Predictive’s proprietary tests include ARTGuideTM and FertilityDXTM. ARTGuide is a blood test that assesses a woman’s endometriosis risk and other genetic causes of infertility. FertilityDX is a comprehensive test and service, using the parental genetic assessment as the map, to guide the journey to successful pregnancy and a healthy newborn. Predictive’s tests are processed at the Company’s state-of-the-art CAP and CLIA accredited laboratory, equipping physicians with the most robust diagnostic tools to provide personalized treatment for their patients.